Beyond cytokines, some chemokines are also implicated in the severity of COVID-19, acting as chemoattractants for immune cells, such as CCL2 or CXCL10, which contribute to the amplification of the inflammatory response (55). This evidence concerns the gene CCL2 and COVID-19.